Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 3 of 3 publications.

Earnshaw S, McDade C, Dodoo C, Huynh Z, Zhang K, Chang SN. Economic impact of multiplex point-of-care testing for chlamydia trachomatis, neisseria gonorrhoeae, and mycoplasma genitalium: development of a modeling framework. Poster to be given at the ISPOR 2025; May 14, 2025. Montréal, Canada.

Meyers JL, Madhwani S, Rausch D, Candrilli SD, Krishnarajah G, Yan S. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccin Immunother. 2017 Aug 3;13(8):1861-72.

Yan S, Meyers J, Candrilli SD, Rausch D, Madhwani S, Krishnarajah G. A real-world health care cost analysis for immunocompetent herpes zoster patients greater than or equal to 50 years old, using an employer-based database in the United States. Presented at the 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy; September 2015. San Diego, CA.